Evidence map›Paper›PMID 28913971›Full record

ReviewAngewandte Chemie (International ed. in English)2018

Nanobodies: Chemical Functionalization Strategies and Intracellular Applications.

Dominik Schumacher, Jonas Helma, Anselm F L Schneider, Heinrich Leonhardt, Christian P R Hackenberger

Abstract readReview
In one paragraph

Review in Angewandte Chemie (International ed. in English), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 109 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
109citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

109 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Orthogonal Site-Specific Dual Bioconjugation of Aryl and Alkyl Thiols.Journal of the American Chemical Society · 2025
    Article
  18. Article
  19. Trends in nanobody radiotheranostics.European journal of nuclear medicine and molecular imaging · 2025
    Review
  20. Article

49 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dominik SchumacherChemical Biology, Leibniz-Forschungsinstitut für Molekulare, Pharmakologie and Department of Chemistry, Humboldt-Universität zu Berlin, Berlin, Germany.ORCID 0000-0001-7095-6858
Jonas HelmaDepartment of Biology II, Ludwig Maximilians Universität München und Center for Integrated Protein Science Munich, Martinsried, Germany.ORCID 0000-0001-6158-452X
Anselm F L SchneiderChemical Biology, Leibniz-Forschungsinstitut für Molekulare, Pharmakologie and Department of Chemistry, Humboldt-Universität zu Berlin, Berlin, Germany.
Heinrich LeonhardtDepartment of Biology II, Ludwig Maximilians Universität München und Center for Integrated Protein Science Munich, Martinsried, Germany.
Christian P R Hackenberger

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanobodies can be seen as next-generation tools for the recognition and modulation of antigens that are inaccessible to conventional antibodies. Due to their compact structure and high stability, nanobodies see frequent usage in basic research, and their chemical functionalization opens the way towards promising diagnostic and therapeutic applications. In this Review, central aspects of nanobody functionalization are presented, together with selected applications. While early conjugation strategies relied on the random modification of natural amino acids, more recent studies have focused on the site-specific attachment of functional moieties. Such techniques include chemoenzymatic approaches, expressed protein ligation, and amber suppression in combination with bioorthogonal modification strategies. Recent applications range from sophisticated imaging and mass spectrometry to the delivery of nanobodies into living cells for the visualization and manipulation of intracellular antigens.

Indexed as

Amino AcidsAnimalsAntigensHumansMass SpectrometryNeoplasmsSingle-Domain AntibodiesAmino AcidsAntigensSingle-Domain Antibodiesantigen-binding proteinscellular deliverymolecular biologynanobodiessite-specific functionalization

Identifiers

PMID28913971
PMCPMC5838514

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.